cagrisema semaglutide cagrilintide combination trial Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study Cagrilintide–semaglutide (CagriSema) as an add-on

Fouad Hachem, recommended I try tirzepatide through MDWatch and thats when everything finally started moving again

If Serena makes it aspirational and Costco makes it attainable, the rest of us better make it relevant

Starting at 1.0 mg significantly increases the risk of nausea, vomiting, and other gastrointestinal side effects

Avoid Alcohol : Patients are advised not to drink alcohol as it can worsen side effects

Where endocrinologists and diabetes specialists have historically prescribed GLP-1s, other provider specialties are either finding greater value in both the diabetes and non-diabetes benefits of new GLP-1s, and/or patients are requesting them

the vote outcome was pending at last check